TABLE 1.
The relationship between RPL34 expression and clinicopathologic features of cervical cancer
| Clinicopathologic feature | N (%) | RPL34 (mean ± SE) | P‐value |
|---|---|---|---|
| Age | |||
| <40 | 20 (21.51) | 0.58 ± 0.20 | .109 |
| ≥40 | 73 (78.49) | 0.23 ± 0.06 | |
| Histology | |||
| Squamous cell cancer | 59 (63.44) | 0.34 ± 0.08 | .775 |
| Adenocarcinoma | 27 (29.03) | 0.26 ± 0.11 | |
| Others | 7 (7.53) | 0.20 ± 0.13 | |
| Clinical staging | |||
| I | 55 (59.14) | 0.47 ± 0.10 | .000 |
| II/III | 38 (40.86) | 0.07 ± 0.02 | |
| Differentiation | |||
| Well to moderate | 58 (62.37) | 0.27 ± 0.08 | .539 |
| Poor | 35 (37.63) | 0.35 ± 0.11 | |
| Lymphatic vascular space invasion | |||
| No | 76 (81.72) | 0.30 ± 0.07 | .852 |
| Yes | 17 (18.28) | 0.33 ± 0.16 | |
| Lymph node metastasis | |||
| Negative | 76 (81.72) | 0.34 ± 0.08 | .008 |
| Positive | 17 (18.28) | 0.12 ± 0.03 | |